Sulfinpyrazone

This classification denotes a uricosuric agent with the molecular formula C23H20N2O3S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier V6OFU47K3W, chemically known as 3,5-pyrazolidinedione, 1,2-diphenyl-4-(2-(phenylsulfinyl)ethyl)- but generally known as sulfinpyrazone, which bears US NIH Compound Identifier 5342. European Medicines Agency schedules Sulfinpyrazone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10737MIG. The term SULFINPYRAZONE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 16, No. 3 1962, List 4). World Health Organization schedules sulfinpyrazone in its Anatomical Therapeutic Chemical (ATC) Classification. SULFINPYRAZONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule sulfinpyrazone under HS 29331990 and SITC 51571. As of Q4 2014, SULFINPYRAZONE remains the US FDA Preferred Term for this commodity. Sulfinpyrazone bears US NLM identifiers UMLS ID C0038742 and NCI Concept Code C47739. SMILES: S(=O)(CCC1C(=O)N(N(C1=O)C1CCCCC1)C1CCCCC1)C1CCCCC1.